Literature DB >> 18583964

ESR1 gene amplification in breast cancer: a common phenomenon?

Lindsay A Brown, Jeremy Hoog, Suet-Feung Chin, Yu Tao, Abd Alnaser Zayed, Koei Chin, Andrew E Teschendorff, John F Quackenbush, John C Marioni, Samuel Leung, Charles M Perou, Torsten O Neilsen, Matthew Ellis, Joe W Gray, Philip S Bernard, David G Huntsman, Carlos Caldas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18583964      PMCID： PMC2846830          DOI： 10.1038/ng0708-806

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  8 in total

Review 1.  Fluorescent in situ hybridization on tissue microarrays: challenges and solutions.

Authors:  Lindsay A Brown; David Huntsman
Journal:  J Mol Histol       Date:  2007-01-10       Impact factor: 2.611

2.  Resolving the resolution of array CGH.

Authors:  Bradley P Coe; Bauke Ylstra; Beatriz Carvalho; Gerrit A Meijer; Calum Macaulay; Wan L Lam
Journal:  Genomics       Date:  2007-02-02       Impact factor: 5.736

3.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

Authors:  Koei Chin; Sandy DeVries; Jane Fridlyand; Paul T Spellman; Ritu Roydasgupta; Wen-Lin Kuo; Anna Lapuk; Richard M Neve; Zuwei Qian; Tom Ryder; Fanqing Chen; Heidi Feiler; Taku Tokuyasu; Chris Kingsley; Shanaz Dairkee; Zhenhang Meng; Karen Chew; Daniel Pinkel; Ajay Jain; Britt Marie Ljung; Laura Esserman; Donna G Albertson; Frederic M Waldman; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

4.  Global variation in copy number in the human genome.

Authors:  Richard Redon; Shumpei Ishikawa; Karen R Fitch; Lars Feuk; George H Perry; T Daniel Andrews; Heike Fiegler; Michael H Shapero; Andrew R Carson; Wenwei Chen; Eun Kyung Cho; Stephanie Dallaire; Jennifer L Freeman; Juan R González; Mònica Gratacòs; Jing Huang; Dimitrios Kalaitzopoulos; Daisuke Komura; Jeffrey R MacDonald; Christian R Marshall; Rui Mei; Lyndal Montgomery; Kunihiro Nishimura; Kohji Okamura; Fan Shen; Martin J Somerville; Joelle Tchinda; Armand Valsesia; Cara Woodwark; Fengtang Yang; Junjun Zhang; Tatiana Zerjal; Jane Zhang; Lluis Armengol; Donald F Conrad; Xavier Estivill; Chris Tyler-Smith; Nigel P Carter; Hiroyuki Aburatani; Charles Lee; Keith W Jones; Stephen W Scherer; Matthew E Hurles
Journal:  Nature       Date:  2006-11-23       Impact factor: 49.962

5.  Prognostic relevance of gene amplifications and coamplifications in breast cancer.

Authors:  Khawla Al-Kuraya; Peter Schraml; Joachim Torhorst; Coya Tapia; Boriana Zaharieva; Hedvika Novotny; Hanspeter Spichtin; Robert Maurer; Martina Mirlacher; Ossi Köchli; Markus Zuber; Holger Dieterich; Friedrich Mross; Kim Wilber; Ronald Simon; Guido Sauter
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

6.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Authors:  Frederik Holst; Phillip R Stahl; Christian Ruiz; Olaf Hellwinkel; Zeenath Jehan; Marc Wendland; Annette Lebeau; Luigi Terracciano; Khawla Al-Kuraya; Fritz Jänicke; Guido Sauter; Ronald Simon
Journal:  Nat Genet       Date:  2007-04-08       Impact factor: 38.330

7.  Human and mouse oligonucleotide-based array CGH.

Authors:  Paul van den Ijssel; Marianne Tijssen; Suet-Feung Chin; Paul Eijk; Beatriz Carvalho; Erik Hopmans; Henne Holstege; Dhinoth Kumar Bangarusamy; Jos Jonkers; Gerrit A Meijer; Carlos Caldas; Bauke Ylstra
Journal:  Nucleic Acids Res       Date:  2005-12-16       Impact factor: 16.971

8.  High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

Authors:  Suet F Chin; Andrew E Teschendorff; John C Marioni; Yanzhong Wang; Nuno L Barbosa-Morais; Natalie P Thorne; Jose L Costa; Sarah E Pinder; Mark A van de Wiel; Andrew R Green; Ian O Ellis; Peggy L Porter; Simon Tavaré; James D Brenton; Bauke Ylstra; Carlos Caldas
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583
  8 in total
  23 in total

1.  Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.

Authors:  Susan E Olivo-Marston; Leah E Mechanic; Steen Mollerup; Elise D Bowman; Alan T Remaley; Michele R Forman; Vidar Skaug; Yun-Ling Zheng; Aage Haugen; Curtis C Harris
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

Review 2.  Mechanisms of aromatase inhibitor resistance.

Authors:  Cynthia X Ma; Tomás Reinert; Izabela Chmielewska; Matthew J Ellis
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

3.  Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.

Authors:  Jim-Ray Chen; Tsan-Yu Hsieh; Huang-Yang Chen; Kun-Yan Yeh; Kuo-Su Chen; Yi-Che ChangChien; Mariann Pintye; Liang-Che Chang; Cheng-Cheng Hwang; Hui-Ping Chien; Yuan-Chun Hsu
Journal:  Virchows Arch       Date:  2014-04-23       Impact factor: 4.064

4.  Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.

Authors:  Ahmed Basudan; Nolan Priedigkeit; Ryan J Hartmaier; Ethan S Sokol; Amir Bahreini; Rebecca J Watters; Michelle M Boisen; Rohit Bhargava; Kurt R Weiss; Maria M Karsten; Carsten Denkert; Jens-Uwe Blohmer; Jose P Leone; Ronald L Hamilton; Adam M Brufsky; Esther Elishaev; Peter C Lucas; Adrian V Lee; Steffi Oesterreich
Journal:  Mol Cancer Res       Date:  2018-10-24       Impact factor: 5.852

5.  ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.

Authors:  Anne-Vibeke Laenkholm; Ann Knoop; Bent Ejlertsen; Tine Rudbeck; Maj-Britt Jensen; Sven Müller; Anne Elisabeth Lykkesfeldt; Birgitte Bruun Rasmussen; Kirsten Vang Nielsen
Journal:  Mol Oncol       Date:  2012-05-08       Impact factor: 6.603

6.  Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Authors:  B Ejlertsen; J Aldridge; K V Nielsen; M M Regan; K L Henriksen; A E Lykkesfeldt; S Müller; R D Gelber; K N Price; B B Rasmussen; G Viale; H Mouridsen
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

Review 7.  Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Authors:  Frederik Holst
Journal:  World J Clin Oncol       Date:  2016-04-10

8.  Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.

Authors:  Rinath Jeselsohn; Roman Yelensky; Gilles Buchwalter; Garrett Frampton; Funda Meric-Bernstam; Ana Maria Gonzalez-Angulo; Jaime Ferrer-Lozano; Jose A Perez-Fidalgo; Massimo Cristofanilli; Henry Gómez; Carlos L Arteaga; Jennifer Giltnane; Justin M Balko; Maureen T Cronin; Mirna Jarosz; James Sun; Matthew Hawryluk; Doron Lipson; Geoff Otto; Jeffrey S Ross; Addie Dvir; Lior Soussan-Gutman; Ido Wolf; Tamar Rubinek; Lauren Gilmore; Stuart Schnitt; Steven E Come; Lajos Pusztai; Philip Stephens; Myles Brown; Vincent A Miller
Journal:  Clin Cancer Res       Date:  2014-01-07       Impact factor: 12.531

Review 9.  Mechanisms of estrogen receptor-α upregulation in breast cancers.

Authors:  Yasuo Miyoshi; Keiko Murase; Masaru Saito; Michiko Imamura; Koushi Oh
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

Review 10.  The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer.

Authors:  Sasha M Pejerrey; Derek Dustin; Jin-Ah Kim; Guowei Gu; Yassine Rechoum; Suzanne A W Fuqua
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.